Skip to content

what is the role of mindfulness in breast cancer survivors.

Role of mindfulness based intervention on behavioral and inflammatory parameters in breast cancer survivors in Eastern India: A Randomised Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055461
Enrollment
100
Registered
2023-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast

Interventions

Intervention1: mindfulness based intervention(MBI): offline supervised session: once a week for 6 weeks online supervised session: once a month for 3 months Control Intervention1: waitlist: No interve

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Breast cancer survivors stage 0 to IIIa who would have completed cancer treatment within the past 3 years (except for tamoxifen/aromatase inhibitors). They should be at least 2 months postsurgery or adjuvant therapy or radiation, whichever occurred later.

Exclusion criteria

Exclusion criteria: â??Exclusion criteria would be patients on active therapy, inflammatory breast cancer, anemia, diabetes, chronic obstructive pulmonary disease, uncontrolled hypertension, evidence of liver or kidney failure, symptomatic ischemic heart disease, conditions involving the immune system such as autoimmune and/or inflammatory diseases, cognitive impairment, alcohol/drug abuse, current yoga practice (within the last 6 months), and/or previous yoga practice for more than 3 months. Women reporting 5 hours or more of vigorous physical activity per week will also be excluded.

Design outcomes

Primary

MeasureTime frame
perceived stress and depression: PPS (Perceived Stress Scale) and HADSTimepoint: baseline, 6 weeks, 3 months

Secondary

MeasureTime frame
Effect on inflammatory markers: IL-6, interleukin-1 beta , C reactive protein and human TNF Effect on serum cortisol levels.1Timepoint: baseline, 6 weeks, 3 months

Countries

India

Contacts

Public ContactChandni Sinha

AIIMS Patna

chandni.doc@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026